The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples